Stocksigma LogoStocksigma Logo

Dr. Lal PathLabs Schedules Board Meeting on 4th Nov'26 for Q2 Results

Dr. Lal PathLabs Limited will convene a Board of Directors meeting on 4th Nov'26 to consider and approve the unaudited standalone and consolidated

Dr. Lal PathLabs Schedules Board Meeting on 4th Nov'26 for Q2 Results

Dr. Lal PathLabs Ltd 路 Intimation 路 04 Nov 2026, 5:30 am

Dr. Lal PathLabs Schedules Board Meeting on 4th Nov'26 for Q2 Results Dr. Lal PathLabs Limited will convene a Board of Directors meeting on 4th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ending 30th Sep'26. In compliance with SEBI insider trading regulations, the company's trading window for dealing in its securities will remain closed from 1st Oct'26 through 6th Nov'26 (both days inclusive).

Original exchange filing (PDF)

More announcements from Dr. Lal PathLabs Ltd

  • Attached 路 11 Nov 2026
  • Attached 路 10 Nov 2026
  • Attached 路 05 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
  • Attached 路 04 Nov 2026

All Dr. Lal PathLabs Ltd announcements